Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04124692 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of Sculptra Aesthetic for Correction of Cheek Wrinkles
A NA study of Cheek Wrinkles, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 149
- Enrollment target
- 13
- Study locations
NCT04124692 is a NA study of Cheek Wrinkles that has completed, run by Galderma R&D. The registered enrollment target is 149 participants. The trial reports 13 study locations across 9 states.
The verdict
NCT04124692, a NA study of Cheek Wrinkles, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 149 participants
- Enrollment target
- 13
- Study locations
Study Summary
The study has been designed to evaluate the safety and effectiveness of Sculptra Aesthetic as a single regimen for correction of cheek wrinkles after changes in reconstitution and injection procedures compared to the approved label.
Conditions Studied
Interventions
- DEVICE Sculptra Aesthetic new dilution
Study Locations (13)
California
- Galderma Research Site - Encino
- Galderma Research Site - Redondo Beach
- Galderma Research Site - San Diego
New York
- Galderma Research Site - New York
- Galderma Research Site - New York
Texas
- Galderma Research Site - Dallas
- Galderma Research Site - Spring
Arizona
- Galderma Research Site - Scottsdale
District of Columbia
- Galderma Research Site - Washington D.C.
Florida
- Galderma Research Site - Coral Gables
Georgia
- Galderma Research Site - Alpharetta
Louisiana
- Galderma Research Site - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2019-11-12 |
| Est. Completion | 2021-08-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04124692
The ClinicalTrials.gov registry entry for NCT04124692 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cheek Wrinkles appearing as the primary indexed condition, and to 1 intervention - of which Sculptra Aesthetic new dilution is the first listed.
NCT04124692 reports 13 study locations spanning 9 distinct geographic areas - top geographies include California, New York, Texas.
Frequently Asked Questions
What is clinical trial NCT04124692 about?
NCT04124692 is a clinical study titled "Safety and Effectiveness of Sculptra Aesthetic for Correction of Cheek Wrinkles". The study has been designed to evaluate the safety and effectiveness of Sculptra Aesthetic as a single regimen for correction of cheek wrinkles after changes in reconstitution and injection procedures compared to the approved label.
What is the current status of trial NCT04124692?
This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2019-11-12. Estimated completion is 2021-08-12.
What conditions does trial NCT04124692 study?
This clinical trial studies the following conditions: Cheek Wrinkles.
What interventions are being tested in trial NCT04124692?
The interventions under investigation include: Sculptra Aesthetic new dilution (DEVICE).
Who is sponsoring clinical trial NCT04124692?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04124692 being conducted?
This trial has 13 study locations across Arizona, California, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cheek Wrinkles
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.